| Literature DB >> 35409625 |
Jason J Ong1,2, Christopher K Fairley1,2, Ria Fortune1, Melanie Bissessor1, Chantal Maloney1, Henrietta Williams1, Adrian Castro3, Lea Castro3, Jason Wu3, Pei Sue Lee4, Eric P F Chow1,2, Marcus Y Chen1,2.
Abstract
Improving access to sexual health services is critical in light of rising sexually transmitted infections (STIs). We evaluated a hub-and-spoke model for improving access to sexual health services in three general practices in Victoria, Australia. The primary outcome was the impact on HIV and STI (chlamydia, gonorrhoea, syphilis) testing. Segmented linear regression analysis was conducted to examine the trends in the total HIV/STI tests pre- (from January 2019 to June 2020) and post-implementation (from July 2020 to July 2021). We evaluated the feasibility and acceptability of integrating this model into the general practices using semi-structured individual interviews. There was a statistically significant rise in testing for HIV and STIs in all general practices: post-implementation, there was an increase of an average of 11.2 chlamydia tests per month (p = 0.026), 10.5 gonorrhoea tests per month (p = 0.001), 4.3 syphilis tests per month (p = 0.010), and 5.6 HIV tests per month (p = 0.010). Participants reported increases in knowledge level and confidence in offering STI testing and managing a greater variety of sexual health cases. This study demonstrates the feasibility of implementing a hub-and-spoke model to enable GPs to deliver sexual health care with support from a sexual health specialist service.Entities:
Keywords: HIV; general practice; hub and spoke; primary care; sexual health; sexually transmitted infection
Mesh:
Year: 2022 PMID: 35409625 PMCID: PMC8998128 DOI: 10.3390/ijerph19073935
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
The average number of HIV/STI tests.
| Before Implementation—Average Number per Month (SD) | After Implementation—Average Number per Month (SD) | ||
|---|---|---|---|
|
| |||
| Clinic 1 | 16.7 (5.6) | 35.5 (15.5) | <0.0001 |
| Clinic 2 | 13.1 (4.3) | 55.5 (14.8) | <0.0001 |
| Clinic 3 | 31.8 (6.7) | 64.1 (37.4) | <0.0001 |
| Total | 61.6 (12.5) | 155.1 (57.6) | <0.0001 |
|
| |||
| Clinic 1 | 16.0 (5.6) | 34.9 (13.8) | <0.0001 |
| Clinic 2 | 11.8 (3.8) | 51.1 (12.5) | <0.0001 |
| Clinic 3 | 24.3 (5.8) | 63.3 (38.1) | <0.0001 |
| Total | 52.2 (11.3) | 114.5 (33.0) | <0.0001 |
|
| |||
| Clinic 1 | 20.0 (5.2) | 24.3 (7.9) | <0.0001 |
| Clinic 2 | 12.7 (5.9) | 33.7 (7.4) | <0.0001 |
| Clinic 3 | 20.5 (7.1) | 35.5 (16.1) | <0.0001 |
| Total | 53.2 (12.4) | 93.5 (24.6) | <0.0001 |
|
| |||
| Clinic 1 | 21.1 (5.0) | 24.6 (7.9) | <0.0001 |
| Clinic 2 | 23.3 (6.6) | 34.3 (7.3) | <0.0001 |
| Clinic 3 | 24.4 (11.6) | 40.4 (18.1) | <0.0001 |
| Total | 68.8 (17.6) | 99.3 (26.5) | <0.0001 |
SD = standard deviation.
Figure 1Number of tests for chlamydia before and after the hub-and-spoke model was launched.
Figure 2Number of tests for gonorrhoea before and after the hub-and-spoke model was launched.
Figure 3Number of tests for syphilis before and after the hub-and-spoke model was launched.
Figure 4Number of tests for HIV before and after the hub-and-spoke model.